These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 12232782)
1. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E. Laws SM; Hone E; Taddei K; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN Mol Psychiatry; 2002; 7(8):886-90. PubMed ID: 12232782 [TBL] [Abstract][Full Text] [Related]
2. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study. Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196 [TBL] [Abstract][Full Text] [Related]
4. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
5. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Cui T; Zhou X; Jin W; Zheng F; Cao X Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein C-I expression in the brain in Alzheimer's disease. Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391 [TBL] [Abstract][Full Text] [Related]
7. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028 [TBL] [Abstract][Full Text] [Related]
8. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele. Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457 [TBL] [Abstract][Full Text] [Related]
9. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Bray NJ; Jehu L; Moskvina V; Buxbaum JD; Dracheva S; Haroutunian V; Williams J; Buckland PR; Owen MJ; O'Donovan MC Hum Mol Genet; 2004 Nov; 13(22):2885-92. PubMed ID: 15385439 [TBL] [Abstract][Full Text] [Related]
10. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women. Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217 [TBL] [Abstract][Full Text] [Related]
11. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease. Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Lahiri DK; Sambamurti K; Bennett DA Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744 [TBL] [Abstract][Full Text] [Related]
13. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease. Bullido MJ; Valdivieso F Microsc Res Tech; 2000 Aug; 50(4):261-7. PubMed ID: 10936877 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Bartzokis G; Lu PH; Geschwind DH; Edwards N; Mintz J; Cummings JL Arch Gen Psychiatry; 2006 Jan; 63(1):63-72. PubMed ID: 16389198 [TBL] [Abstract][Full Text] [Related]
16. alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease. Licastro F; Chiappelli M; Thal LJ; Masliah E Arch Gerontol Geriatr Suppl; 2004; (9):243-51. PubMed ID: 15207421 [TBL] [Abstract][Full Text] [Related]
17. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease. Beyer K; Lao JI; Latorre P; Ariza A Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900 [TBL] [Abstract][Full Text] [Related]
18. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Licastro F; Porcellini E; Caruso C; Lio D; Corder EH Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778 [TBL] [Abstract][Full Text] [Related]
19. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease. Maloney B; Ge YW; Alley GM; Lahiri DK J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398 [TBL] [Abstract][Full Text] [Related]